Endoscopic Retrograde Cholangiopancreatography
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Patients undergoing ERCPs at Methodist Dallas Medical Center.
- Who it may be relevant to
- Registry conditions: Gastro-Intestinal Disorder. Basic parameters: from 15 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Endoscopic Retrograde Cholangiopancreatography Patient Registry
Overview
The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.
Detailed description
The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.
Interventions
- Other Patients undergoing ERCPs at Methodist Dallas Medical Center
The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.
Primary outcome measures
- Underwent ERCP [Time frame: 25 years]
Eligibility criteria
Inclusion criteria
Patients >15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025
Exclusion criteria
Patients <15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
United States · 1 center
- Methodist Dallas Medical Center- Clinical Research Institute — Dallas
Identifiers
NCT: NCT07490132 · 046.GID.2024.D